By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Akesis Pharmaceuticals 



La Jolla  California    U.S.A.
Phone: n/a Fax:


SEARCH JOBS


Industry
Pharmaceutical






Company News
Akesis Pharmaceuticals Discontinues Sole Clinical Development Program and Announces Intent to File for Chapter 7 Bankruptcy 1/22/2009 6:46:08 AM
Akesis Pharmaceuticals Announces Pipeline Expansion Strategy 11/6/2008 11:16:20 AM
Akesis Pharmaceuticals Appoints Carl LeBel as CEO and Jay Lichter as Executive Chairman 11/5/2008 6:45:13 AM
Akesis Pharmaceuticals Enters into Bridge Financing Transaction 9/30/2008 8:51:37 AM
Akesis Pharmaceuticals Expands Preclinical Safety Program for Lead Product 9/22/2008 9:50:54 AM
Akesis Pharmaceuticals Names Christos Mantzoros, MD, DSc to its Scientific Advisory Board 7/18/2008 10:18:33 AM
Akesis Pharmaceuticals Names Carl LeBel as President and Chief Operating Officer 6/30/2008 9:47:24 AM
Akesis Pharmaceuticals and Charles River Laboratories (Massachusetts) to Begin 13-Week Animal Study for AKP- 020 6/24/2008 9:55:52 AM
Akesis Pharmaceuticals Reports Positive Results from its Phase IIa Trial of AKP-020 for Type 2 Diabetes 6/17/2008 6:37:33 AM
Akesis Pharmaceuticals Completes Phase IIa Trial of AKP-020 for Type 2 Diabetes 6/4/2008 9:53:04 AM
1234
//-->